{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:00:43Z","timestamp":1762480843558,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.gore.2021.100741","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T14:08:51Z","timestamp":1615126131000},"page":"100741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case series"],"prefix":"10.1016","volume":"36","author":[{"given":"Maya","family":"Yasukawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis A.","family":"Dainty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2021.100741_b0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: a review","volume":"116","author":"D'Angelo","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.gore.2021.100741_b0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1525-1438.2007.01126.x","article-title":"Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease","volume":"18","author":"Einstein","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2021.100741_b0020","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1002\/cncr.28844","article-title":"Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma","volume":"120","author":"George","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.gore.2021.100741_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7800-2-3","article-title":"Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer","volume":"2","author":"Harmon","year":"2005","journal-title":"Int. Semin. Surg. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.23245","article-title":"Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy","volume":"112","author":"Kapp","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.gore.2021.100741_b0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ygyno.2012.02.014","article-title":"Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis","volume":"125","author":"Leitao","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jmig.2014.10.022","article-title":"Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women","volume":"22","author":"Lieng","year":"2015","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.gore.2021.100741_b0045","unstructured":"Network NCC, 2020. NCCN Guidelines Version 1.2020 Uterine Neoplasms."},{"key":"10.1016\/j.gore.2021.100741_b0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2013.11.024","article-title":"The value of re-exploration in patients with inadvertently morcellated uterine sarcoma","volume":"132","author":"Oduyebo","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0055","first-page":"414","article-title":"Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma","volume":"83","author":"Parker","year":"1994","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gore.2021.100741_b0060","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mds545","article-title":"A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group","volume":"24","author":"Pautier","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/IGC.0b013e31819a1f8f","article-title":"Uterine leiomyosarcoma: does the primary surgical procedure matter?","volume":"19","author":"Perri","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2021.100741_b0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000001187","article-title":"Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation","volume":"127","author":"Raine-Bennett","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gore.2021.100741_b0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","article-title":"Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation","volume":"145","author":"Ricci","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0080","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","article-title":"Uterine leiomyosarcoma: A review of the literature and update on management options","volume":"151","author":"Roberts","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000080283","article-title":"Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan","volume":"67","author":"Sagae","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.gore.2021.100741_b0090","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.ejso.2017.08.011","article-title":"Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"43","author":"Sardi","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ccr3.1491","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma","volume":"6","author":"Sardi","year":"2018","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.gore.2021.100741_b0100","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1245\/s10434-015-4960-y","article-title":"Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results","volume":"23","author":"Sugarbaker","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0105","first-page":"29","article-title":"Surgical technology and pharmacology of hyperthermic perioperative chemotherapy","volume":"7","author":"Sugarbaker","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.gore.2021.100741_b0115","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978\u20132001: An analysis of 26,758 cases","volume":"119","author":"Toro","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gore.2021.100741_b0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/gyno.2000.6081","article-title":"Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging","volume":"80","author":"Umesaki","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2021.100741_b0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0959-8049(97)00370-5","article-title":"Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines","volume":"34","author":"van de Vaart","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.gore.2021.100741_b0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gore.2021.100741_b0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijc.29011","article-title":"HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer","volume":"136","author":"Zivanovic","year":"2015","journal-title":"Int. J. Cancer"}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578921000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578921000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:55:51Z","timestamp":1762480551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578921000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":27,"alternative-id":["S2352578921000461"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2021.100741","relation":{},"ISSN":["2352-5789"],"issn-type":[{"type":"print","value":"2352-5789"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case series","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2021.100741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100741"}}